Pharmacotherapy for Overactive Bladder: An Evidence-Based Approach to Selecting an Antimuscarinic Agent

ISSN： 0012-6667

Source： Drugs, Vol.66, Iss.10, 2006-01, pp. : 1361-1370

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The antimuscarinic agent solifenacin succinate can significantly improve symptoms of overactive bladder

Inpharma, Vol. 1, Iss. 1430, 2004-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

The pharmacotherapy of overactive bladder

By Athanasopoulos Anastasios

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 7, 2011-05 ,pp. : 1003-1005

Informa Healthcare

Access to resources Recommend Favorite

Pharmacotherapy of overactive bladder: epidemiology and pathophysiology of overactive bladder

By Latini Jerilyn M Giannantoni Antonella

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 7, 2011-05 ,pp. : 1017-1027

Informa Healthcare

Access to resources Recommend Favorite

Cardiovascular effects of antimuscarinic agents in overactive bladder

By Rosa Gian Marco Bauckneht Matteo Scala Carolina Tafi Emanuela Leone Roberti Maggiore Umberto Ferrero Simone Brunelli Claudio

Expert Opinion on Drug Safety, Vol. 12, Iss. 6, 2013-11 ,pp. : 815-827

Informa Healthcare

Access to resources Recommend Favorite

Maintenance pharmacotherapy of chronic obstructive pulmonary disease: an evidence-based approach

By Dransfield Mark T Bailey William C

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 1, 2005-01 ,pp. : 13-25

Informa Healthcare

Access to resources Recommend Favorite